MMJ is the largest shareholder of Harvest One, owning about 25.8% of the company's issued and outstanding common shares.
Harvest One, based in Vancouver, said the loan will be used for general corporate purposes including the development and rollout of the company's Cannabis 2.0 product line.
"This short-term loan provides us with the flexibility needed to continue the implementation of our enhanced strategic plan while continuing to evaluate longer-term financing options," said Grant Froese, CEO of Harvest One, in a statement.
"There is momentum across our business as we continue to focus on our strengths in brand development and distribution. We see significant opportunities for growth as we leverage our extensive brand portfolio as Cannabis 2.0 takes hold in Canada."
Harvest One is focused on building and supporting its existing line of value-added infused products. This includes the manufacturing of its Satipharm Gelpell capsules in Canada, cannabis-infused Dream Water and LivRelief products, vape pens and other derivative offerings.
The company said a review of its non-core assets is ongoing as it seeks to reduce its overall exposure to pure cultivation and redirect its efforts and resources on brand development, production and distribution.
Harvest One has said it believes the sale of these non-core assets will provide cash proceeds to support the expansion of the company's core business lines and operational strengths.
The MMJ loan carries an interest rate of 15% per annum and the principal and accrued interest on the loan is payable in arrears within 60 days of the issue date
Harvest One said it will grant MMJ a security interest in all current and after-acquired property of the company and subsidiaries.
Harvest One stock closed up 7.5% to US$0.13 in New York and 6.7% to C$016 in Canada.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham